624 related articles for article (PubMed ID: 18395186)
41. Inactivation of O6-methylguanine-DNA methyltransferase in soft tissue sarcomas: association with K-ras mutations.
Kim JI; Suh JT; Choi KU; Kang HJ; Shin DH; Lee IS; Moon TY; Kim WT
Hum Pathol; 2009 Jul; 40(7):934-41. PubMed ID: 19356788
[TBL] [Abstract][Full Text] [Related]
42. Effects of 4'-modified analogs of aristeromycin on the metabolism of S-adenosyl-L-homocysteine in murine L929 cells.
Ault-Riché DB; Lee Y; Yuan CS; Hasobe M; Wolfe MS; Borcherding DR; Borchardt RT
Mol Pharmacol; 1993 Jun; 43(6):989-97. PubMed ID: 8316227
[TBL] [Abstract][Full Text] [Related]
43. Generating mutations but providing chemosensitivity: the role of O6-methylguanine DNA methyltransferase in human cancer.
Esteller M; Herman JG
Oncogene; 2004 Jan; 23(1):1-8. PubMed ID: 14712205
[TBL] [Abstract][Full Text] [Related]
44. A comparison of human O6-methylguanine-DNA methyltransferase promoter activity in Mer+ and Mer- cells.
Harris LC; Potter PM; Remack JS; Brent TP
Cancer Res; 1992 Nov; 52(22):6404-6. PubMed ID: 1423289
[TBL] [Abstract][Full Text] [Related]
45. Regulation of expression of the DNA repair gene O6-methylguanine-DNA methyltransferase via protein kinase C-mediated signaling.
Boldogh I; Ramana CV; Chen Z; Biswas T; Hazra TK; Grösch S; Grombacher T; Mitra S; Kaina B
Cancer Res; 1998 Sep; 58(17):3950-6. PubMed ID: 9731508
[TBL] [Abstract][Full Text] [Related]
46. Extended O6-methylguanine methyltransferase promoter hypermethylation following n-butylidenephthalide combined with 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) on inhibition of human hepatocellular carcinoma cell growth.
Yu YL; Yu SL; Su KJ; Wei CW; Jian MH; Lin PC; Tseng IH; Lin CC; Su CC; Chan DC; Lin SZ; Harn HJ; Chen YL
J Agric Food Chem; 2010 Feb; 58(3):1630-8. PubMed ID: 20043672
[TBL] [Abstract][Full Text] [Related]
47. Promoter methylation of O(6)-methylguanine-DNA-methyltransferase in lung cancer is regulated by p53.
Lai JC; Cheng YW; Goan YG; Chang JT; Wu TC; Chen CY; Lee H
DNA Repair (Amst); 2008 Aug; 7(8):1352-63. PubMed ID: 18555750
[TBL] [Abstract][Full Text] [Related]
48. The correlation between promoter methylation status and the expression level of O6-methylguanine-DNA methyltransferase in recurrent glioma.
Suzuki T; Nakada M; Yoshida Y; Nambu E; Furuyama N; Kita D; Hayashi Y; Hayashi Y; Hamada J
Jpn J Clin Oncol; 2011 Feb; 41(2):190-6. PubMed ID: 21148162
[TBL] [Abstract][Full Text] [Related]
49. Promoter hypermethylation of the O6-methylguanine-DNA methyltransferase gene: more common in lung adenocarcinomas from never-smokers than smokers and associated with tumor progression.
Pulling LC; Divine KK; Klinge DM; Gilliland FD; Kang T; Schwartz AG; Bocklage TJ; Belinsky SA
Cancer Res; 2003 Aug; 63(16):4842-8. PubMed ID: 12941804
[TBL] [Abstract][Full Text] [Related]
50. Impact of O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation and MGMT expression on dacarbazine resistance of Hodgkin's lymphoma cells.
Kewitz S; Stiefel M; Kramm CM; Staege MS
Leuk Res; 2014 Jan; 38(1):138-43. PubMed ID: 24284332
[TBL] [Abstract][Full Text] [Related]
51. Loss expression of O6-methylguanine DNA methyltransferase by promoter hypermethylation and its relationship to betel quid chewing in oral squamous cell carcinoma.
Huang SH; Lee HS; Mar K; Ji DD; Huang MS; Hsia KT
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Jun; 109(6):883-9. PubMed ID: 20451846
[TBL] [Abstract][Full Text] [Related]
52. Methylation of selected CpGs in the human O6-methylguanine-DNA methyltransferase promoter region as a marker of gene silencing.
Danam RP; Qian XC; Howell SR; Brent TP
Mol Carcinog; 1999 Feb; 24(2):85-9. PubMed ID: 10078935
[TBL] [Abstract][Full Text] [Related]
53. Epigenetic silencing of the MGMT gene in cancer.
Soejima H; Zhao W; Mukai T
Biochem Cell Biol; 2005 Aug; 83(4):429-37. PubMed ID: 16094446
[TBL] [Abstract][Full Text] [Related]
54. O6-methylguanine-DNA methyltransferase expression strongly correlates with outcome in childhood malignant gliomas: results from the CCG-945 Cohort.
Pollack IF; Hamilton RL; Sobol RW; Burnham J; Yates AJ; Holmes EJ; Zhou T; Finlay JL
J Clin Oncol; 2006 Jul; 24(21):3431-7. PubMed ID: 16849758
[TBL] [Abstract][Full Text] [Related]
55. Extent and patterns of MGMT promoter methylation in glioblastoma- and respective glioblastoma-derived spheres.
Sciuscio D; Diserens AC; van Dommelen K; Martinet D; Jones G; Janzer RC; Pollo C; Hamou MF; Kaina B; Stupp R; Levivier M; Hegi ME
Clin Cancer Res; 2011 Jan; 17(2):255-66. PubMed ID: 21097691
[TBL] [Abstract][Full Text] [Related]
56. Glycogen synthase kinase 3β inhibition sensitizes human glioblastoma cells to temozolomide by affecting O6-methylguanine DNA methyltransferase promoter methylation via c-Myc signaling.
Pyko IV; Nakada M; Sabit H; Teng L; Furuyama N; Hayashi Y; Kawakami K; Minamoto T; Fedulau AS; Hamada J
Carcinogenesis; 2013 Oct; 34(10):2206-17. PubMed ID: 23715499
[TBL] [Abstract][Full Text] [Related]
57. Prognostic impact of O6-methylguanine-DNA methyltransferase silencing in patients with recurrent glioblastoma multiforme who undergo surgery and carmustine wafer implantation: a prospective patient cohort.
Metellus P; Coulibaly B; Nanni I; Fina F; Eudes N; Giorgi R; Barrie M; Chinot O; Fuentes S; Dufour H; Ouafik L; Figarella-Branger D
Cancer; 2009 Oct; 115(20):4783-94. PubMed ID: 19637364
[TBL] [Abstract][Full Text] [Related]
58. MGMT: key node in the battle against genotoxicity, carcinogenicity and apoptosis induced by alkylating agents.
Kaina B; Christmann M; Naumann S; Roos WP
DNA Repair (Amst); 2007 Aug; 6(8):1079-99. PubMed ID: 17485253
[TBL] [Abstract][Full Text] [Related]
59. S-Adenosylhomocysteine hydrolase overexpression in HEK-293 cells: effect on intracellular adenosine levels, cell viability, and DNA methylation.
Hermes M; Osswald H; Riehle R; Piesch C; Kloor D
Cell Physiol Biochem; 2008; 22(1-4):223-36. PubMed ID: 18769049
[TBL] [Abstract][Full Text] [Related]
60. [Detection of O6-methylguanine-DNA methyltransferase promoter methylation in chemotherapy for glioma].
Zheng CQ; Ji SP; Gong F; Li AM; Tai JL; Zhang YP
Ai Zheng; 2009 Jun; 28(6):575-80. PubMed ID: 19635193
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]